Discover
DMAC
DiaMedica Therapeutics Inc.
7.44
2 x 5.34
2 x 8.98
bid
ask
+
0.40
5.68%
2 @ 04:00 PM
7.88 +0.44 (5.89%)
| Ytd | -6.53% | |
| 1y | 108.40% |
6.98
day range
7.49
3.48
52 week range
10.42
| Open | 7.02 | Prev Close | 7.04 | Low | 6.98 | High | 7.49 | Mkt Cap | 400.89M |
| Vol | 275.99K | Avg Vol | 192.81K | EPS | -0.71 | P/E | N/A | Forward P/E | -7.26 |
| Beta | 1.46 | Short Ratio | 3.88 | Inst. Own | 31.61% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-06 | 50-d Avg | 6.09 | 200-d Avg | 7.17 | 1yr Est | 7.00 |
| Income Statement | |||
| Operating Expenses | 10.04M | ||
| Research and Development Expense | 7.99M | ||
| Selling, General and Administrative Expense | 2.50M | ||
| Operating Income | -10.03M | ||
| Income Tax Expense | 7.00K | ||
| Net Income | -10.12M | ||
| Net Income Common Stock | -10.12M | ||
| Net Income Common Stock (USD) | -10.12M | ||
| Consolidated Income | -10.04M | ||
| Net Income to Non-Controlling Interests | 76.00K | ||
| Earnings per Basic Share | -0.19 | ||
| Earnings per Basic Share (USD) | -0.19 | ||
| Earnings per Diluted Share | -0.19 | ||
| Earning Before Interest & Taxes (EBIT) | -10.11M | ||
| Earning Before Interest & Taxes (USD) | -10.11M | ||
| Weighted Average Shares | 53.79M | ||
| Weighted Average Shares Diluted | 53.79M | ||
| Balance Sheet | |||
| Cash and Equivalents | 4.87M | ||
| Cash and Equivalents (USD) | 4.87M | ||
| Investments | 46.46M | ||
| Investments Current | 46.46M | ||
| Trade and Non-Trade Receivables | 301.00K | ||
| Current Assets | 52.36M | ||
| Property, Plant & Equipment Net | 317.00K | ||
| Total Assets | 53.08M | ||
| Debt Current | 115.00K | ||
| Total Debt | 212.00K | ||
| Current Liabilities | 5.75M | ||
| Debt Non-Current | 97.00K | ||
| Total Liabilities | 5.85M | ||
| Accumulated Retained Earnings (Deficit) | -182.81M | ||
| Accumulated Other Comprehensive Income | -26.00K | ||
| Shareholders Equity | 47.24M | ||
| Shareholders Equity (USD) | 47.24M | ||
| Assets Non-Current | 717.00K | ||
| Total Debt (USD) | 212.00K | ||
| Liabilities Non-Current | 97.00K | ||
| Trade and Non-Trade Payables | 3.29M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 33.00K | ||
| Net Cash Flow from Financing | 417.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -10.78M | ||
| Capital Expenditure | -8.00K | ||
| Issuance (Purchase) of Equity Shares | 420.00K | ||
| Issuance (Repayment) of Debt Securities | -3.00K | ||
| Net Cash Flow from Investing | -2.11M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -2.11M | ||
| Net Cash Flow from Operations | -9.08M | ||
| Share Based Compensation | 822.00K | ||